During the last session, Unicycive Therapeutics Inc (NASDAQ:UNCY)’s traded shares were 1.03 million, with the beta value of the company hitting 2.24. At the end of the trading day, the stock’s price was $0.55, reflecting an intraday loss of -1.98% or -$0.01. The 52-week high for the UNCY share is $1.73, that puts it down -214.55 from that peak though still a striking 63.64% gain since the share price plummeted to a 52-week low of $0.20. The company’s market capitalization is $57.14M, and the average trade volume was 1.12 million shares over the past three months.
Unicycive Therapeutics Inc (UNCY) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. UNCY has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.07.
Unicycive Therapeutics Inc (NASDAQ:UNCY) trade information
Unicycive Therapeutics Inc (UNCY) registered a -1.98% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.98% in intraday trading to $0.55, hitting a weekly high. The stock’s 5-day price performance is -2.48%, and it has moved by -8.45% in 30 days. Based on these gigs, the overall price performance for the year is -63.05%.
Unicycive Therapeutics Inc (UNCY) estimates and forecasts
In the rating firms’ projections, revenue will decrease -100.00% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -77.09%. While earnings are projected to return 59.82% in 2025.
UNCY Dividends
Unicycive Therapeutics Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 3.47 million shares, is of LOGOS GLOBAL MANAGEMENT LP’s that is approximately 9.9389% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.74 million.
